India’s REITs and InvITs Set for ₹20 Trillion Milestone by 2030
Source: Economictimes
Arth Insight · What this means for your wallet
- Investment in REITs and InvITs is expected to grow by ₹11.6 trillion by 2030.
- Total assets under management in this sector could double to reach ₹20 trillion.
- Growth will be driven by mutual funds, insurers, and global institutional investors.
India's real estate and infrastructure investment trusts are expected to see a massive influx of ₹11.6 trillion in new capital over the next six years. This growth could double the total assets under management to ₹20 trillion, offering a significant boost to passive income options for retail investors.
- ▸Investment in REITs and InvITs is expected to grow by ₹11.6 trillion by 2030.
- ▸Total assets under management in this sector could double to reach ₹20 trillion.
- ▸Growth will be driven by mutual funds, insurers, and global institutional investors.
- ▸Retail investors will have more opportunities to earn passive income from infrastructure and real estate.
- ✓Investment in REITs and InvITs is expected to grow by ₹11.6 trillion by 2030.
- ✓Total assets under management in this sector could double to reach ₹20 trillion.
- ✓Growth will be driven by mutual funds, insurers, and global institutional investors.
- ✓Retail investors will have more opportunities to earn passive income from infrastructure and real estate.
India’s alternative investment landscape is on the verge of a massive transformation. According to a recent report by financial services firm Avendus Capital, the combined market for Real Estate Investment Trusts (REITs) and Infrastructure Investment Trusts (InvITs) is projected to attract an additional ₹11.6 trillion in investments by 2030.
The Road to ₹20 Trillion
Currently, these investment vehicles have gained steady ground as reliable tools for income generation. However, the next six years are expected to see a rapid acceleration. The report suggests that the total Assets Under Management (AUM) for the sector could surge beyond the ₹20 trillion mark by 2030, effectively doubling the current market size.
This growth is being fueled by a diverse group of stakeholders. While global institutional investors have historically been the backbone of these trusts, the next phase of expansion is expected to be driven by domestic players, including:
- Mutual Funds: Increasing their exposure to yield-generating assets.
- Insurance Companies: Seeking long-term, stable returns to match their liabilities.
- Pension Funds: Looking for inflation-beating assets with lower volatility than traditional equity.
- Global Investors: Continuing to view India as a high-growth hub for infrastructure and Grade-A commercial real estate.
What This Means for Retail Investors
For the average Indian investor, the expansion of REITs and InvITs represents a maturing market for passive income. Traditionally, investing in large-scale infrastructure projects like toll roads or premium office buildings required massive capital. REITs and InvITs have democratized this, allowing individuals to own a fractional share of these assets and receive regular dividends from the income they generate.
The projected influx of ₹11.6 trillion suggests that many more assets—ranging from data centers and warehouses to renewable energy parks—will likely be listed on the exchanges. This provides retail investors with more choices to diversify their portfolios away from the volatility of direct stocks and the lower returns of traditional fixed deposits.
Future Outlook
As the regulatory environment continues to evolve to protect small investors and enhance transparency, the trust in these instruments is growing. With the government’s continued focus on infrastructure development and the rising demand for premium commercial spaces, the 2030 target reflects a bullish sentiment on India's long-term economic structural growth.
Investment in REITs and InvITs are subject to market risks; please read all scheme-related documents carefully and consult a financial advisor before investing.
Loan interest rates, processing fees and eligibility are set by the lender and subject to credit approval — verify current terms before applying. Some listings may be sponsored. Not financial advice.
Frequently Asked Questions
What is the difference between a REIT and an InvIT?
A REIT (Real Estate Investment Trust) focuses on income-generating real estate like offices and malls, while an InvIT (Infrastructure Investment Trust) invests in infrastructure projects like highways and power grids.
How do these investments help retail investors?
They allow individual investors to earn regular dividends from large-scale properties and infrastructure projects without needing to buy or manage the physical assets themselves.
Why is the market expected to double by 2030?
Growth is expected due to increased participation from domestic institutions like pension funds and mutual funds, alongside a massive supply of new infrastructure and commercial projects.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about real-estate
BreakingPiramal Pharma Slashes China Reliance to Under 10% for Supply Chain Resilience
Piramal Pharma has significantly reduced its dependence on Chinese raw materials to less than 10%. This strategic move aims to enhance supply chain resilience against geopolitical risks, with the company expanding its manufacturing footprint to India, the UK, and the US.
Dr Reddy's Pivots to Generic Semaglutide, Biosimilars for Future Growth
Dr Reddy's Laboratories is strategically focusing on the relaunch of generic semaglutide and expanding its biosimilars portfolio to drive future growth. This comes as the company navigates mixed results, with domestic formulations business growing but North American Revlimid sales declining in the September quarter.
Aayush Wellness Launches Calcium & Vitamin D Tablets, Enters ₹1.35 Lakh Crore Bone Health Market
Aayush Wellness Limited has launched new calcium and vitamin D tablets, marking its entry into India's significant bone and joint health segment. This expansion reflects the growing consumer demand for preventive healthcare and nutritional supplements designed to support musculoskeletal health.
Related Stories
BreakingPiramal Pharma Slashes China Reliance to Under 10% for Supply Chain Resilience
Piramal Pharma has significantly reduced its dependence on Chinese raw materials to less than 10%. This strategic move aims to enhance supply chain resilience against geopolitical risks, with the company expanding its manufacturing footprint to India, the UK, and the US.
Dr Reddy's Pivots to Generic Semaglutide, Biosimilars for Future Growth
Dr Reddy's Laboratories is strategically focusing on the relaunch of generic semaglutide and expanding its biosimilars portfolio to drive future growth. This comes as the company navigates mixed results, with domestic formulations business growing but North American Revlimid sales declining in the September quarter.
Aayush Wellness Launches Calcium & Vitamin D Tablets, Enters ₹1.35 Lakh Crore Bone Health Market
Aayush Wellness Limited has launched new calcium and vitamin D tablets, marking its entry into India's significant bone and joint health segment. This expansion reflects the growing consumer demand for preventive healthcare and nutritional supplements designed to support musculoskeletal health.
NITI Aayog Eyes Policy Reforms to Boost India's Medical Device Manufacturing
NITI Aayog is actively exploring new policy measures to enhance India's domestic manufacturing capabilities for medical and dental devices. The initiative addresses significant hurdles like complex regulations and cost disadvantages faced by local producers. The goal is to strengthen the 'Make in India' drive within the crucial healthcare sector.